Stockpolly
Search
FBRX · NASDAQ · Biotechnology

Forte Biosciences (FBRX)

Develops the anti-CD122 antibody candidate FB102 for autoimmune and autoimmune-related diseases.

$76.99
At close0.00 (0.00%)
Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions71 holders · as of Mar 31, 202663.69%13.52M shares
Otherremainder36.31%7.71M shares

21.23M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Federated Hermes, Inc.Institution
8.32%1.77M13Fas of Mar 31, 2026
Fred Alger Management, LLCInstitution
6.00%1.27M13Fas of Mar 31, 2026
Orbimed Advisors LLCInstitution
5.64%1.20M13Fas of Mar 31, 2026
Janus Henderson Group PLCInstitution
5.60%1.19M13Fas of Mar 31, 2026
Affinity Asset Advisors, LLCInstitution
4.77%1.01M13Fas of Mar 31, 2026
Bioimpact Capital LLCInstitution
4.71%1.00M13Fas of Mar 31, 2026
Adage Capital Partners GP, L.L.C.Institution
4.47%950,00013Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution
2.50%531,69213Fas of Mar 31, 2026
Morgan StanleyInstitution
2.36%500,29813Fas of Mar 31, 2026
Cable Car Capital LLCInstitution
1.88%400,00013Fas of Mar 31, 2026
FMR LLCInstitution
1.60%340,69513Fas of Mar 31, 2026
Millennium Management LLCInstitution
1.59%337,98313Fas of Mar 31, 2026
Woodline Partners LPInstitution
1.56%331,98713Fas of Mar 31, 2026
Citadel Advisors LLCInstitution
1.10%233,36913Fas of Mar 31, 2026
Awm Investment Company, Inc.Institution
0.94%200,00013Fas of Mar 31, 2026
Sphera Funds Management Ltd.Institution
0.87%184,98413Fas of Mar 31, 2026
Marshall Wace, LLPInstitution
0.71%150,30713Fas of Mar 31, 2026
Integral Health Asset Management, LLCInstitution
0.71%150,00013Fas of Mar 31, 2026
Susquehanna International Group, LLPInstitution
0.63%133,49413Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution
0.59%125,44213Fas of Mar 31, 2026
Ikarian Capital, LLCInstitution
0.56%118,97213Fas of Mar 31, 2026
Lord, Abbett & Co. LLCInstitution
0.54%114,63513Fas of Mar 31, 2026
Ameriprise Financial IncInstitution
0.53%111,78813Fas of Mar 31, 2026
Russell Investments Group, Ltd.Institution
0.43%91,77213Fas of Mar 31, 2026
Qube Research & Technologies LtdInstitution
0.40%85,96913Fas of Mar 31, 2026

13F — a manager's quarterly holdings

Institutions13F, as of Mar 31, 2026

71 holders · 13.52M shares · 20 new positions · 40 increased · 21 reduced · 10 closed

HolderShares% outstandingChg q/qFiled
Federated Hermes, Inc.1.77M8.32%0May 11, 2026
Fred Alger Management, LLC1.27M6.00%−187.0KMay 15, 2026
Orbimed Advisors LLC1.20M5.64%0May 15, 2026
Janus Henderson Group PLC1.19M5.60%−237.7KMay 18, 2026
Affinity Asset Advisors, LLC1.01M4.77%+22.4KMay 14, 2026
Bioimpact Capital LLC1.00M4.71%+1.00MnewMay 15, 2026
Adage Capital Partners GP, L.L.C.950.0K4.47%+616.7KMay 15, 2026
Vanguard Capital Management LLC531.7K2.50%+531.7KnewMay 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Federated Hermes, Inc.13.15%1.64M13GOct 7, 2025 ↗
Alger Associates, Inc.10.20%624.3K13GMay 15, 2026 ↗
Janus Henderson Group PLC9.99%1.39M13GMay 15, 2026 ↗
Tybourne Capital Management (HK) Ltd9.99%1.27M13GAug 4, 2025 ↗
Affinity Asset Advisors, LLC7.30%1.01M13GMay 14, 2026 ↗
MPM BioImpact LLC7.20%1.00M13GMay 15, 2026 ↗
Adage Capital Management, L.P.6.84%950.0K13GMay 13, 2026 ↗
Nemean Asset Management, LLC6.76%432.3K13GJan 10, 2025 ↗
Boothbay Fund Management, LLC6.00%13GFeb 13, 2025 ↗

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Dec 30, 2025
Antony A. Rileyofficer: CHIEF FINANCIAL OFFICER
Purchase9,680$26.3341,520

CongressHouse and Senate disclosures

Not reported.